Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant mva encoding 4-1bbl (cd137l) and/or cd40l
AU2019354101A1
Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an immune checkpoint antagonist or agonist
AU2019336940A1
Storage improved poxvirus compositions
AU2018389786A1
Methods and compositions for inducing an immune response against hepatitis B virus (HBV)
AU2018283811A1
Poxvirus vectors encoding HIV antigens, and methods of use thereof
CN110198733A
For enhancing the composition and method of the stability of poxvirus transgenic
US2017137820A1
Agonists and antagonists of toll-like receptor (tlr) 13
WO2017129765A1
Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
US2017081642A1
Recombinant poxvirus vector comprising tetanus toxin fragment c
SG10202000447YA
Promoters for enhancing expression in poxviruses
BR112018002172A2
promoters to enhance poxvirus expression
CN107709554A
Restructuring is through modifying vaccinia virus ankara (MVA) foot and mouth disease virus (FMDV) vaccine
AU2015323736A1
Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellin
CA2960096A1
Methods and compositions for enhancing immune responses
CA2960092A1
Vaccine combination including vectors comprising nucleic acid encoding antigens from filovirus subtypes
CN106999565A
Vaccinia virus ankara (MVA) filamentous virus vaccine of recombinant modified
AU2015203893A1
Optimized early-late promoter combined with repeated vaccination favors cytotoxic t cell response against antigens in replication deficient recombinant virus vaccines
EP3142689A1
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and a monoclonal antibody against tim-3
US2017106065A1
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of TIM-3
EP3116541A1
Use of oil and water emulsions for increasing b cell responses with modified vaccinia ankara virus